Dexamethasone-induced decrease in HMG-CoA reductase and protein-farnesyl transferase activities does not impair ras processing in AR 4-2 J cells

Molecular and Cellular Biochemistry

Volumn 202, Issue 1-2, 1999, Pages 101-108

  Lambert, Monique ^a   Bui, Ngoc Diem ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

HMG CoA reductase; Protein farnesyl transferase; ras processing

Indexed keywords

DEXAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; PROTEIN FARNESYLTRANSFERASE; RAS PROTEIN;

ACINAR CELL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; ISOPRENYLATION; NONHUMAN; PLEIOTROPY; PROTEIN PROCESSING; RAT; REGULATORY MECHANISM;

ALKYL AND ARYL TRANSFERASES; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DEXAMETHASONE; GENES, RAS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MEVALONIC ACID; PANCREATIC NEOPLASMS; RATS; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0033379416     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007016403736     Document Type: Article

References (41)

1. Newman CMH, Magee AI: Posttranslational processing of the ras superfamily of small GTP-binding proteins. Biochim Biophys Acta 1155: 79-96, 1993
2. Clarke S: Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Ann Rev Biochem 61: 355-386, 1992
3. Hancock JF, Cadwallader K, Paterson H, Marshall CJ: A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J 10: 4033-4039, 1991
4. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ: Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci (USA) 89: 6403-6407, 1992
5. ras farnesyl: Protein transferase by Cys-AAX tetrapeptides. Cell 62: 81-88, 1990
6. ras protein farnesyltransferase. Proc Natl Acad Sci (USA) 88: 11368-11372, 1991
7. ras farnesyltransferase, the counterpart of yeast DPR1/RAM1. Cell 66: 327-334, 1991
8. Zhang FL, Moomaw JF, Casey PJ: Properties and kinetic mechanism of recombinant mammalian protein geranylgeranyltransferase type I. J Biol Chem 269: 23465-23470, 1994
9. Yokoyama K, McGeady P, Gelb MH: Mammalian geranylgeranyl-transferase-I: Substrate specificity, kinetic mechanism, metal requirements, and affinity labeling. Biochem 34: 1344-1354, 1995
10. Casey PJ, Seabra MC: Protein prenyltransferases. J Biol Chem 271: 5289-5292, 1996
11. Goalstone ML, Draznin B: Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes. J Biol Chem 271: 27585-27589, 1996
12. Goalstone M, Carel K, Leitner JW, Draznin B: Insulin stimulates the phosphorylation and activity of farnesyltransferase via the ras-mitogen-activated proteinkinase pathway. Endocrinology 138: 5119-5124, 1997
13. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343: 425-430, 1990
14. Jiang G, McKenzie TL, Conrad DG, Shechter I: Transcriptional regulation by lovastatin and 25-hydroxycholesterol in HepG2 cells and molecular cloning and expression of the cDNA for the human hepatic squalene synthase. J Biol Chem 268: 12818-12824, 1993
15. Grünler J, Ericsson J, Dallner G: Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta 1212: 259-277, 1994
16. Hinson DD, Chambliss KL, Toth MJ, Tanaka RD, Gibson KM: Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. J Lipid Res 38: 2216-2223, 1997
17. Logsdon CD, Moessner J, Williams JA, Goldfine ID: Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR4-2J cells. J Cell Biol 100: 1200-1208, 1985
18. Lambert M, Bui ND, Christophe J: Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J. Reg Pep 32: 151-167, 1991
19. Estival A, Pradel P, Wicker-Planquart C, Vaysse N, Puigserver A, Clemente F: Regulation of amylase and chymotrypsinogen expression by dexamethasone and caerulein in serum-free cultured pancreatic acinar AR4-2J cells. Biochem J 279: 197-201, 1991
20. B) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells. Reg Pep 52: 31-38, 1994
21. Seva C, Dickinson CJ, Yamada T: Growth-promoting effects of glycine-extended progastrin. Science 265: 410-412, 1994
22. Svoboda M, Dupuche MH, Lambert M, Bui D, Christophe J: Internalization-sequestration and degradation of cholecystokinin (CCK) in tumoral rat pancreatic AR 4-2J cells. Biochim Biophys Acta 1055: 207-216, 1990
23. Bernfeld P: Amylases, α and β. Meth Enzymol 1: 149-158, 1955
24. Goldstein JL, Brown MS, Stradley SJ, Reiss Y, Gierasch LM: Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase. J Biol Chem 266: 15575-15578, 1991
25. Cuthbert JA, Lipsky PE: Suppression of the proliferation of ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism. Cancer Res 55: 1732-1740, 1995
26. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
27. Gourlet P, Svoboda M, Cauvin A, Christophe J: The sensitivity of dot immunoassay for the peptides helodermin, histidine-isoleucinamide (PHI) and histidine-methioninamide (PHM) increases after peptide cross-linking to proteins prefixed on nitrocellulose. J Immunol Meth 133: 151-157, 1990
28. Svoboda M, Tastenoy M, Vertongen P, Robberecht P: Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol 105: 131-137, 1994
29. Maltese WA, Sheridan KM: Isoprenylated proteins in cultured cells: Subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J Cell Physiol 133: 471-481, 1987
30. Schmidt RA, Schneider CJ, Glomset JA: Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell. J Biol Chem 259: 10175-10180, 1984
31. Rosewics S, Logsdon CD: Glucocorticoids stimulate ornithine decarboxylase gene expression in pancreatic AR42J cells. Gastroenterology 101: 1102-1108, 1991
32. Rosewicz S, Riecken EO, Kaiser A: Transient stabilization of cholecystokinin A receptor mRNA by glucocorticoids in pancreatic AR42J cells. Am J Physiol 267: G772-G777, 1994
33. Rosewicz S, Detjen K, Kaiser A, Prosenc N, Cervos-Navarro J, Riecken EO, Haller H: Bombesin receptor gene expression in rat pancreatic acinar AR42J cells: Transcriptional regulation by glucocorticoids. Gastroenterology 107:208-218, 1994
34. Rosewicz S, Detjen K, Logsdon CD, Chen LM, Chao J, Riecken EO: Glandular kallikrein gene expression is selectively down-regulated by glucocorticoids in pancreatic AR42J cells. Endocrinology 128:2216-2222, 1991
35. Rosewicz S, McDonald AR, Maddux BA, Goldfine ID, Miesfeld RL, Logsdon CD: Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 263: 2581-2584, 1988
36. Klengel R, Piiper A, Pittelkow S, Zeuzem S: Differential expression of Rab3 isoforms during differentiation of pancreatic acinar cell line AR42J. Biochem Biophys Res Commun 236: 719-722, 1997
37. Gibbs JB, Oliff A: The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Ann Rev Pharmacol Toxicol 37: 143-166, 1997
38. Cox AD, Der CJ: Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras? Biochim Biophys Acta 1333: F51-F71, 1997
39. Sinensky M, Beck LA, Leonard S, Evans R: Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J Biol Chem 265: 19937-19941, 1990
40. Gadbut AP, Wu L, Tang D, Papageorge A, Watson JA, Galper JB: Induction of the cholesterol metabolic pathway regulates the farnesylation of RAS in embryonic chick heart cells: A new role for Ras in regulating the expression of muscarinic receptors and G proteins. Embo J 16: 7250-7260, 1997
41. Agarwal R, Khan SG, Athar M, Zaidi SIA, Bickers DR, Mukhtar H: ras Protein p21 processing enzyme farnesyltransferase in chemical carcinogen-induced murine skin tumors. Mol Carcinogen 8: 290-298, 1993